Ischemia-Reperfusion Injury Reduces Kidney Folate Transporter Expression and Plasma Folate Levels

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2021 Jun 21

PMID 34149715

Citations 7

Authors

Cheng Yang

Charith U B Wijerathne

Guo-Wei Tu

Connie W H Woo

Yaw L Siow

Susara Madduma Hewage

Kathy K W Au-Yeung

Tongyu Zhu

Karmin O

Affiliations

Soon will be listed here.

Abstract

Acute or chronic kidney disease can cause micronutrient deficiency. Patients with end-stage renal disease, kidney transplantation or on dialysis have reduced circulating levels of folate, an essential B vitamin. However, the molecular mechanism is not well understood. Reabsorption of folate in renal proximal tubules through folate transporters is an important process to prevent urinary loss of folate. The present study investigated the impact of acute kidney injury (AKI) on folate transporter expression and the underlying mechanism. AKI was induced in Sprague-Dawley rats that were subjected to kidney ischemia (45 min)-reperfusion (24 h). Both male and female rats displayed kidney injury and low plasma folate levels compared with sham-operated rats. The plasma folate levels were inversely correlated to plasma creatinine levels. There was a significant increase in neutrophil gelatinase-associated lipocalin (NGAL) and IL-6 mRNA expression in the kidneys of rats with ischemia-reperfusion, indicating kidney injury and increased inflammatory cytokine expression. Ischemia-reperfusion decreased mRNA and protein expression of folate transporters including folate receptor 1 (FOLR1) and reduced folate carrier (RFC); and inhibited transcription factor Sp1/DNA binding activity in the kidneys. Simulated ischemia-reperfusion through hypoxia-reoxygenation or Sp1 siRNA transfection in human proximal tubular cells inhibited folate transporter expression and reduced intracellular folate levels. These results suggest that ischemia-reperfusion injury downregulates renal folate transporter expression and decreases folate uptake by tubular cells, which may contribute to low folate status in AKI. In conclusion, ischemia-reperfusion injury can downregulate Sp1 mediated-folate transporter expression in tubular cells, which may reduce folate reabsorption and lead to low folate status.

Citing Articles

Transcription factor specificity protein (SP) family in renal physiology and diseases.

Zhou W, Fang J, Jia Q, Meng H, Liu F, Mao J PeerJ. 2025; 13():e18820.

PMID: 39850832 PMC: 11756367. DOI: 10.7717/peerj.18820.

Intelligent Ureteral Stent Placeable via Standard Procedure for Kidney Pressure Telemetry: An Ex-Vivo Study.

Yousefi Darestani M, Lange D, Chew B, Takahata K Ann Biomed Eng. 2024; 53(1):180-192.

PMID: 39316307 DOI: 10.1007/s10439-024-03610-0.

Folate as a potential treatment for lethal ventricular arrhythmias in TANGO2-deficiency disorder.

Xu W, Cao Y, Stephens S, Arredondo M, Chen Y, Perez W JCI Insight. 2024; 9(11).

PMID: 38855866 PMC: 11382877. DOI: 10.1172/jci.insight.171005.

Therapeutic strategies targeting folate receptor α for ovarian cancer.

Mai J, Wu L, Yang L, Sun T, Liu X, Yin R Front Immunol. 2023; 14:1254532.

PMID: 37711615 PMC: 10499382. DOI: 10.3389/fimmu.2023.1254532.

Reduced folate carrier 1 is present in retinal microvessels and crucial for the inner blood retinal barrier integrity.

Gurler G, Belder N, Beker M, Sever-Bahcekapili M, Uruk G, Kilic E Fluids Barriers CNS. 2023; 20(1):47.

PMID: 37328777 PMC: 10276430. DOI: 10.1186/s12987-023-00442-3.

References

Scott R, Quaggin S . Review series: The cell biology of renal filtration. J Cell Biol. 2015; 209(2):199-210. PMC: 4411276. DOI: 10.1083/jcb.201410017. View

Teschner M, Kosch M, Schaefer R . Folate metabolism in renal failure. Nephrol Dial Transplant. 2002; 17 Suppl 5:24-7. DOI: 10.1093/ndt/17.suppl_5.24. View

Hwang S, Siow Y, Au-Yeung K, House J, O K . Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney. Am J Physiol Renal Physiol. 2010; 300(1):F189-98. DOI: 10.1152/ajprenal.00272.2010. View

Birn H, Spiegelstein O, Christensen E, Finnell R . Renal tubular reabsorption of folate mediated by folate binding protein 1. J Am Soc Nephrol. 2005; 16(3):608-15. DOI: 10.1681/ASN.2004080711. View

Crider K, Bailey L, Berry R . Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients. 2012; 3(3):370-84. PMC: 3257747. DOI: 10.3390/nu3030370. View

Selhub J, Emmanouel D, Stavropoulos T, Arnold R . Renal folate absorption and the kidney folate binding protein. I. Urinary clearance studies. Am J Physiol. 1987; 252(4 Pt 2):F750-6. DOI: 10.1152/ajprenal.1987.252.4.F750. View

Saikawa Y, Price K, Hance K, Chen T, Elwood P . Structural and functional analysis of the human KB cell folate receptor gene P4 promoter: cooperation of three clustered Sp1-binding sites with initiator region for basal promoter activity. Biochemistry. 1995; 34(31):9951-61. DOI: 10.1021/bi00031a018. View

Bagherieh M, Kheirollahi A, Zamani-Garmsiri F, Emamgholipour S, Meshkani R . Folic acid ameliorates palmitate-induced inflammation through decreasing homocysteine and inhibiting NF-κB pathway in HepG2 cells. Arch Physiol Biochem. 2021; 129(4):893-900. DOI: 10.1080/13813455.2021.1878539. View

Hertzberg D, Ryden L, Pickering J, Sartipy U, Holzmann M . Acute kidney injury-an overview of diagnostic methods and clinical management. Clin Kidney J. 2017; 10(3):323-331. PMC: 5466115. DOI: 10.1093/ckj/sfx003. View

10.

Prathapasinghe G, Siow Y, O K . Detrimental role of homocysteine in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2007; 292(5):F1354-63. DOI: 10.1152/ajprenal.00301.2006. View

11.

Fortin M, Amyot S, Geadah D, LeBlanc M . Serum concentrations and clearances of folic acid and pyridoxal-5-phosphate during venovenous continuous renal replacement therapy. Intensive Care Med. 1999; 25(6):594-8. DOI: 10.1007/s001340050908. View

12.

Canepa A, Carrea A, Caridi G, Dertenois L, Minniti G, Cerone R . Homocysteine, folate, vitamin B12 levels, and C677T MTHFR mutation in children with renal failure. Pediatr Nephrol. 2003; 18(3):225-9. DOI: 10.1007/s00467-002-1058-0. View

13.

Sid V, Siow Y, O K . Role of folate in nonalcoholic fatty liver disease. Can J Physiol Pharmacol. 2017; 95(10):1141-1148. DOI: 10.1139/cjpp-2016-0681. View

14.

Capelli I, Cianciolo G, Gasperoni L, Zappulo F, Tondolo F, Cappuccilli M . Folic Acid and Vitamin B12 Administration in CKD, Why Not?. Nutrients. 2019; 11(2). PMC: 6413093. DOI: 10.3390/nu11020383. View

15.

Yang C, Zhao T, Zhao Z, Jia Y, Li L, Zhang Y . Serum-stabilized naked caspase-3 siRNA protects autotransplant kidneys in a porcine model. Mol Ther. 2014; 22(10):1817-28. PMC: 4428396. DOI: 10.1038/mt.2014.111. View

16.

Tran T, Shatnawi A, Zheng X, Kelley K, Ratnam M . Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. Cancer Res. 2005; 65(10):4431-41. DOI: 10.1158/0008-5472.CAN-04-2890. View

17.

Woo C, Prathapasinghe G, Siow Y, O K . Hyperhomocysteinemia induces liver injury in rat: Protective effect of folic acid supplementation. Biochim Biophys Acta. 2006; 1762(7):656-65. DOI: 10.1016/j.bbadis.2006.05.012. View

18.

Venkatachalam M, Bernard D, Donohoe J, LEVINSKY N . Ischemic damage and repair in the rat proximal tubule: differences among the S1, S2, and S3 segments. Kidney Int. 1978; 14(1):31-49. DOI: 10.1038/ki.1978.87. View

19.

Koeze J, Keus F, Dieperink W, van der Horst I, Zijlstra J, van Meurs M . Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria. BMC Nephrol. 2017; 18(1):70. PMC: 5319106. DOI: 10.1186/s12882-017-0487-8. View

20.

Steiber A, Kopple J . Vitamin status and needs for people with stages 3-5 chronic kidney disease. J Ren Nutr. 2011; 21(5):355-68. DOI: 10.1053/j.jrn.2010.12.004. View